Effects of immune complex formation and complement activation on circulating platelets in the primate

Clinical Immunology

Volumn 91, Issue 1, 1999, Pages 99-105

  Birmingham, Daniel J ^a   Hebert, Lee A ^a   Shen, Xiao Ping ^a   Higgins, Paul ^b   Yeh, C Grace ^b   Creasey, Abla A ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b CytoMed Inc   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Complement; Immune complexes; Primate platelets

Indexed keywords

COMPLEMENT COMPONENT C3A; IMMUNOGLOBULIN;

ANIMAL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BIOSYNTHESIS; BLOOD; BLOOD CELL COUNT; CATTLE; COMPARATIVE STUDY; COMPLEMENT ACTIVATION; IMMUNIZATION; IMMUNOLOGY; MACACA; METABOLISM; MOUSE; RABBIT; RAT; SPECIES DIFFERENCE; THROMBOCYTE; THROMBOCYTE COUNT;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; BLOOD CELL COUNT; BLOOD PLATELETS; CATTLE; COMPLEMENT ACTIVATION; COMPLEMENT C3A; GAMMA-GLOBULINS; IMMUNIZATION; MACACA FASCICULARIS; MICE; PLATELET COUNT; RABBITS; RATS; SPECIES SPECIFICITY;

EID: 0033109223     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1998.4677     Document Type: Article

References (31)

1. Nelson, D. S., Immune adherence. Adv. Immunol. 3, 131-180, 1963.
2. Birmingham, D. J., Erythrocyte complement receptors. Crit. Rev. Immunol. 15, 133-154, 1995.
3. Birmingham, D. J., Logar, C. M., Shen, X.-P., and Chen, W., The baboon erythrocyte complement receptor is a glycophosphatidy-linositol-linked protein encoded by a homologue of the human CR1-like genetic element. J. Immunol. 157, 2586-2592, 1996.
4. Manthei, U., Nickells, M. W., Barnes, S. H., Ballard, L. L., Cui, W. Y., and Atkinson, J. P., Identification of a C3b/iC3 binding protein of rabbit platelets and leukocytes. A CR1-like candidate for the immune adherence receptor. J. Immunol. 140, 1228-1235, 1988.
5. Quigg, R. J., and Holers, V. M., Characterization of rat complement receptors and regulatory proteins:platelets is distinct from CR1. J. Immunol. 155, 1481-1488, 1995.
6. Meur, S., Hugli, T., Andreatta, R., Hadding, U., and Bitter-Suermann, D., Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion. Inflammation 5, 263-273, 1981.
7. Meur, S., Ecker, U., Hadding, U., and Bitter-Suermann, D., Platelet-serotonin release by C3a and C5a: Two independent pathways of activation. J. Immunol. 126, 1506-1509, 1981.
8. Gerardy-Schahn, R., Ambrosius, D., Saunders, D., Casaretto, M., Mittler, C., Karwarth, G., Gorgen, S., and Bitter-Suermann, D., Characterization of C3a receptor-proteins on guinea pig platelets and human polymorphonuclear leukocytes. Eur. J. Immunol. 19, 1095-1102, 1989.
9. Fernandez, G. S., Gijon, M. A., Furio, V., Vivanco, F., and Crespo, M. S., Role of complement-derived peptides in thrombocytopenia elicited by soluble aggregates of immunoglobulin G in the rat. Lab. Invest. 60, 705-713, 1989.
10. Polley, M., and Nachman, R., Human platelet activation by C3a and C3a des-arg. J. Exp. Med. 158, 603-615, 1983.
11. Fukuoka, Y., and Hugli, T., Demonstration of a specific C3a receptor on guinea pig platelets. J. Immunol. 140, 3496-3501, 1988.
12. Hawlisch, H., Frank, R., Hennecke, M., Baensch, M., Sohns, B., Arseniev, L., Bautsch, W., Kola, A., Klos, A., and Kohl, J., Sitedirected C3a receptor antibodies from phage display libraries. J. Immunol. 160, 2947-2958, 1998.
13. Yancey, K. B., Lawley, T. J., Dersookian, M., and Harvath, L., Analysis of the interaction of human C5a and C5a des Arg with human monocytes and neutrophils: Flow cytometric and chemotaxis studies. J. Invest. Dermatol. 92, 184-189, 1989.
14. Mahan, J. D., Hebert, L. A., Mcallister, C., Birmingham, D. J., Shen, X. P., Cosio, F. G., and Brandt, J., Platelet involvement in experimental immune complex-mediated glomerulonephritis in the nonhuman primate. Kidney Int. 44, 716-725, 1993.
15. Sindrey, M., Marshall, T., and Naish, P., Quantitative assessment of the effects of platelet depletion in the autologous phase of nephrotoxic serum nephritis. Clin. Exp. Immunol. 36, 90-96, 1979.
16. Fries, J., Mendrick, D., and Rennke, H., Determinants of immune complex-mediated glomerulonephritis. Kidney Int. 34, 333-345, 1988.
17. Johnson, R., Alpers, C., Pritzi, P., Schulze, M., Baker, P., Pruchno, C., and Couser, W., Platelets mediate neutrophil-dependent immune complex nephritis in the rat. J. Clin. Invest. 82, 1225-1235, 1988.
18. Johnson, R., Alpers, C., Pruchno, C., Schulze, M., Baker, P., Pritzl, P., and Couser, W., Mechanisms and kinetics for platelet and neutrophil localization in immune complex nephritis. Kidney Int. 36, 780-789, 1989.
19. Poelstra, K., Hardonk, M., Koudstaal, J., and Bakker, W., Intraglomerular platelet aggregation and experimental glomerulonephritis. Kidney Int. 37, 1500-1508, 1990.
20. Johnson, R., Pritzl, P., and Alpers, C., Platelet-complement interaction in mesangial proliferative nephritis in the rat. Am. J. Pathol. 138, 313-321, 1990.
21. Birmingham, D. J., Hebert, L. A., Cosio, F. G., and VanAman, M. E., Immune complex erythrocyte complement receptor interactions in vivo during induction of glomerulonephritis in nonhuman primates. J. Lab. Clin. Med. 116, 242-252, 1990.
22. Hebert, L. A., Birmingham, D. J., Mahan, J. D., Shen, X. P., McAllister, C., Cosio, F. G., and Dillon, J. J., Effect of chronically increased erythrocyte complement receptors on immune complex nephritis. Kidney Int. 45, 493-499, 1994.
23. Higgins, P. J., Ko, J. L., Lobell, R., Sardonini, C., Alessi, M. K., and Yeh, C. G., A soluble chimeric complement inhibitory protein that possesses both decay-accelerating and factor I cofactor activities. J. Immunol. 158, 2872-2881, 1997.
24. Hammerschmidt, D., Harris, P., Wayland, J., Craddock, P., and Jacob, H., Complement-induced granulocyte aggregation in vivo. Am. J. Pathol. 102, 146-150, 1981.
25. Till, O., Johnson, K., Kunkel, R., and Ward, P., Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites. J. Clin. Invest. 69, 1126-1135, 1982.
26. Sims, P., and Wiedmer, T., The response of human platelets to activated components of the complement system. Immunol. Today 12, 338-342, 1991.
27. Cosgrove, L. J., d'Apice, A. J., Haddad, A., Pedersen, J., and McKenzie, I. F., CR3 receptor on platelets and its role in the prostaglandin metabolic pathway. Immunol. Cell Biol. 65, 453-460, 1987.
28. Nunez, D., Charriaut, M. C., Barel, M., Benveniste, J., and Frade, R., Activation of human platelets through gp140, the C3d/EBV receptor (CR2). Eur. J. Immunol. 17, 515-520, 1987.
29. Vik, D. P., and Fearon, D. T., Cellular distribution of complement receptor type 4 (CR4): Expression on human platelets. J. Immunol. 138, 254-258, 1987.
30. Rosenfeld, S. I., Looney, R. J., Leddy, J. P., Phipps, D. C., Abraham, G. N., and Anderson, C. L., Human platelet Fc receptor for immunoglobulin G. Identification as a 40,000-molecular-weight membrane protein shared by monocytes. J. Clin. Invest. 76, 2317-2322, 1985.
31. Couser, W. G., Johnson, R. J., Young, B. A., Yeh, C. G., Toth, C. A., and Rudolph, A. R., The effects of soluble recombinant complement receptor 1 on complement-mediated experimental glomerulonephritis. J. Am. Soc. Nephrol. 5, 1888-1894, 1995.